Corneal collagen cross-linking (CXL) has increasingly become the hot topic of nearly every conversation amongst corneal experts around the globe. When effective, the procedure provides the best opportunity for arresting or slowing the ectatic progression of the irregular cornea. As the procedure has become more widely accepted by the mainstream medical community, it has placed an increased burden on the referring optometrist to educate, prepare, and manage the irregular cornea patient.
The below questions have been posed to me numerous times over the years. My provided responses, formed from years of engagement in active clinical practice, are not exhaustive. My hope is to provide a level of comfort and knowledge to the co-managing optometrist so that he or she can recommend the procedure with confidence.
Please sign up to become a member to read this and other complete articles.
You do not have access to this post.
